
Overview
Stethome is a company that offers an intelligent home stethoscope designed to detect distinctive sounds related to respiratory health conditions such as bronchitis, pneumonia, and asthma. Their product utilizes AI to identify abnormal sounds and measure important physiological parameters, aiding in the swift and accurate detection of symptoms for effective treatment.
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk.
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 152 days for 2022). 4 of 6 audited by a statutory auditor.
- 202523/07/2026
- 202415/07/2025
- 202321/08/2024
- 202214/12/2023
- 202105/11/2022
- 202021/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Smart stethoscope
- Lung sound analysis software
- Medical auscultation device
Websites
- stethome.comStethoMe® | Smart Stethoscope with Medical AIWebflowGoogle Tag ManagerCloudflare
Authorized Representatives
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 2,937 | $39,667.75 | 22.4868% | |
| 2,023 | $27,323.07 | 15.4889% | |
| 3,230 | $43,625.07 | 24.7301% | |
Others | 4,871 | $65,788.76 | 37.2942% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-05-30.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
16 public aid cases recorded, with a total value of $4,632,505.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 12, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,135$1,135 | Marszałek Województwa Wielkopolskiego | |
| Jun 19, 2023 | Aid for SME access to finance — risk finance aid | $399.5K$399,457 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Nov 17, 2020 | Aid for research and development projects: industrial research | $862.1K$862,117 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Diagnova Technologies sp. z o.o. | $445,925.86 | diagnova.pl | ||
| Medisensonic S.A. | $362,572.63 | medisensonic.com | ||
| RSQ Health sp. z o.o. | $338,557.13 | rsqmotion.pl | ||
| Findair sp. z o.o. | $315,875.61 | findair.eu | ||
| Oasis Diagnostics S.A. | $282,613.94 | oasis-diagnostics.com | ||
| Aidmed sp. z o.o. | $263,700.89 | aidmed.ai | ||
| Gierth sp. z o.o. | $240,006.46 | gierth.pl | ||
| Quantum Innovations sp. z o.o. | $167,489.61 | quantuminnovations.pl | ||
| AUG Medical sp. z o.o. | $141,688.75 | augmedical.pl | ||
| 3 Cam sp. z o.o. | $42,303.18 | 3cam.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-14 | Share capital increase (87,500.00 PLN → 653,050.00 PLN) | |
| 2026-04-14 | PKD change (Removed: 32.50.Z; Added: 32.50.B) | |
| 2022-01-24 | Share capital increase (86,300.00 PLN → 87,500.00 PLN) | |
| 2021-04-30 | Share capital increase (81,950.00 PLN → 86,300.00 PLN) | |
| 2020-11-30 | Share capital increase (71,350.00 PLN → 81,950.00 PLN) |
FAQ
Last updated: 2026-07-23
